Top Markets
#1 ADO Protocol ADO Protocol +193.18%
#2 Islamic Coin Islamic Coin +155.35%
#3 GoPlus Security GoPlus Security +43.24%
#4 GAIB AID GAIB AID +24.67%
#5 Casper Network Casper Network +14.30%
#6 Verus Coin Verus Coin +13.64%
#7 o1.exchange o1.exchange +12.71%
#8 SkyAI SkyAI +12.71%
#9 Pons Pons +11.32%
#10 Starpower Starpower +10.96%
Coin of the day
ADO Protocol ADO Protocol
設定
言語
日本
通貨
USD
テーマ
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc

Apimeds Pharmaceuticals US, Inc

APUS
株式のランク #33689
Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage... Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage biopharmaceutical firm operating within the United States. This company is dedicated to the entire lifecycle of its flagship product, Apitox – from its initial investigation and development to its production, market introduction, and sales. Apitox, a key active pharmaceutical ingredient, is specifically designed to alleviate inflammation and manage pain symptoms experienced by individuals suffering from osteoarthritis and multiple sclerosis. Established in 2020, APUS has its corporate headquarters situated in Hopewell, New Jersey, and operates as a subsidiary of Api Meds, Inc.
株価
$4.70
最終同期: 2026-08-14
時価総額
$7.09M
変化（1日）
-0.21%
変化（1年）
-70.63%
国
US
取引 Apimeds Pharmaceuticals US, Inc (APUS)

カテゴリー

Healthcare
Apimeds Pharmaceuticals US, Inc（APUS）の配当利回りの履歴
Apimeds Pharmaceuticals US, Inc（銘柄コード: APUS）の配当利回り（TTM）は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Apimeds Pharmaceuticals US, Inc（APUS）の2026から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
年 配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り（TTM）
企業 配当利回り 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.48%
BE